Kalkine has a fully transformed New Avatar.
Company Overview: ELMO Software Limited (ASX: ELO) is engaged in offering cloud-based HR, payroll, expense management solutions, to mid-market enterprises and small businesses. The company operates on a Software as a Service (“SaaS”) business model based on recurrent subscription revenues and has its offices in Australia, New Zealand, and the UK.
ELO Details
A Quick Look at 1QFY22 Key Aspects: In FY21, the company completed two significant acquisitions, namely, Breathe and Webexpenses, which aid ELO to expand its market opportunity and propel its growth strategy. The company witnessed robust growth reverting throughout 2HFY21 from the mid-market and in the Breathe segment. The company also bought Vocam, BoxSuite, and HROnboard. These acquisitions lay a strong foundation for long-term and sustainable growth for the company.
ARR Highlights (Source: Company Reports)
Delve Into FY21 Key Aspects:
Key Metrics: In FY21, the company’s cash cycle days stood at 67.9 days compared to FY20 cash cycle days of 78.8.
Liquidity Profile; Analysis by Kalkine Group
Key Recent Update: On 23 November 2021, the company informed the market that it has received consent from the Australian Securities and Investments Commission (ASIC) to change its auditor, effective immediately. In this regard ELO appointed, Grant Thornton Audit Pty Ltd (Grant Thornton) as the company’s new auditor.
Top 10 Shareholders: The top 10 shareholders together form around 57.93% of the total shareholdings, while the top 4 constitutes the maximum holding. Jlab Investments (No. 2) Pty. Ltd. is the entity, holding maximum shares in the company at 15.18%. Immersion Capital LLP is the second-largest shareholder, with a holding of 14.85%, as also highlighted in the chart below:
Top 10 Shareholders; Analysis by Kalkine Group
Risk Analysis: The company faces competition from industry peers, technological changes, and integration risks from various acquisitions. ELO also faces regulatory changes while expanding in new markets of APAC and the UK. ELO’s net loss is increasing on a year-over-year basis. Hence, these mounting losses may throw tough challenges at the company’s overall functioning and may drain liquidity from the balance sheet.
Outlook: The company is bouncing back and increasing confidence in its business, owing to higher adoption of cloud-based business tools, including HR technology as people are remotely working from home, given the current global scenario. FY22 is smoothing up to be a good year for the company, across both mid-market and small business segments penetration in Australia, the UK, and New Zealand. For FY22, the company expects annualised recurring revenue to be between $105 - $111 million, representing 25% to 33% YoY growth. Revenues for the same period are expected to be in the range of $90.5 - $95.5 million, depicting a rise of 31% to 38% on pcp. EBITDA for FY22 is expected to be between $1.0 - $6.0 million.
Valuation Methodology: EV/Sales Multiple Based Relative Valuation (Illustrative)
Source: Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation: In the past year, the stock went down by ~25.16%. The stock just recovered from its 52-week low price of $4.20. The stock has been valued using an EV/Sales multiple based illustrative relative valuation method and arrived at a target price of an upside of low double-digit (in percentage terms). The company might trade at a slight premium to its peers, considering decent liquidity position, high customer retention rates, increase in top-line, the turnaround in EBITDA numbers, and an encouraging outlook, etc. For the purpose of valuation, few peers like Nearmap Ltd (ASX: NEA), Bigtincan Holdings Ltd (ASX: BTH), Nitro Software Ltd (ASX: NTO), and others have been considered. Considering the robust management focus toward growth, new module adoption, growth in ARR, recovery in mid-market segment & small business (Breathe) in 2HFY21, synergies from acquisitions, geographical diversification, positive long-term outlook, current trading level, indicative upside in the valuation, and key risks associated the business, we give a “Speculative Buy” recommendation on the stock at the current market price of $4.76, as on 3 December 2021, 10:45 AM (GMT+10), Sydney, Eastern Australia.
ELO Daily Technical Chart, Data Source: REFINITIV
Technical Indicators Defined:-
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decision should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the Valuation has been achieved and subject to the factors discussed above.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.